Meanwhile, through analyzing microarray data from GENT dataset [29], we found that CHD5 was underexpressed in 366 kidney cancer tissues, 87 bladder cancer tissues and 244 prostate cancer tissues, compared with the corresponding normal tissues (Figure 1A). Here, CHD5 is linked to prostate carcinoma.